Metabolic liver disease in diabetes – From mechanisms to clinical trials

Non-alcoholic fatty liver disease (NAFLD) comprises fatty liver (steatosis), non-alcoholic steatohepatitis (NASH) and fibrosis/cirrhosis and may lead to end-stage liver failure or hepatocellular carcinoma. NAFLD is tightly associated with the most frequent metabolic disorders, such as obesity, metab...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewidar, Bedair, Kahl, Sabine, Pafili, Kalliopi, Roden, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305712/
https://www.ncbi.nlm.nih.gov/pubmed/32569680
http://dx.doi.org/10.1016/j.metabol.2020.154299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305712/
https://www.ncbi.nlm.nih.gov/pubmed/32569680
http://dx.doi.org/10.1016/j.metabol.2020.154299

Ejemplares similares